Zydus Lifesciences Limited announces the execution of undertakings to tender as part of its envisaged tender offer for Amplitude Surgical SA shares

These undertakings to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company's capital and voting rights, may be revoked in the event of a competing tender offer being filed by a third party, declared compliant and opened by the Autorité des marchés financiers. These undertakings to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company's capital and voting rights, may be revoked in the event of a competing tender offer being filed by a third party,...

These undertakings to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company's capital and voting rights, may be revoked in the event of a competing tender offer being filed by a third party, declared compliant and opened by the Autorité des marchés financiers.

The acquisition of the 85.6% block is expected to be completed by June 2025 and the draft tender offer will be filed with the Autorité des marchés financiers upon receipt of regulatory approvals. The opening of the tender offer will then be subject to the clearance decision of the Autorité des marchés financiers.

Logo: https://mma.prnewswire.com/media/2592545/Zydus_Lifesciences_Limited_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/zydus-lifesciences-limited-announces-the-execution-of-undertakings-to-tender-as-part-of-its-envisaged-tender-offer-for-amplitude-surgical-sa-shares-302431316.html